NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
David R Sullivan
i
University of Sydney - Sydney / Australia
Others
AD Scientific Index ID: 121011
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
David R Sullivan's MOST POPULAR ARTICLES
1-)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.A Keech, RJ Simes, P Barter, J Best, R Scott, MR Taskinen, P Forder, ...Lancet (London, England) 366 (9500), 1849-1861, 200535432005
2-)
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levelsLong-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study GroupNew England Journal of Medicine 339 (19), 1349-1357, 199824711998
3-)
Health benefits of herbs and spices: the past, the present, the futureLC Tapsell, I Hemphill, L Cobiac, DR Sullivan, M Fenech, CS Patch, ...15802006
4-)
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trialFJ Raal, EA Stein, R Dufour, T Turner, F Civeira, L Burgess, G Langslet, ...The Lancet 385 (9965), 331-340, 20159272015
5-)
Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumabE Stroes, D Colquhoun, D Sullivan, F Civeira, RS Rosenson, GF Watts, ...Journal of the American College of Cardiology 63 (23), 2541-2548, 20147212014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept